The Standard Echocardiographic Report

Basic Information
• Name and/or identifier of the laboratory, location, contact information.
• Study date.
• Patient identification and demographics, date of birth +/- age, gender.
• Patient location (inpatient vs. outpatient), study location (echo lab, portable – ICU, ER, etc.).
• Height, weight, body surface area.
• Rhythm and heart rate.
• Study indication.
• Referring physician identification.
• Interpreting physician identification.
• Sonographer ID.
• Type of study (e.g., adult TTE, neonatal TTE, TEE, stress echo etc.).
• Study technical quality (e.g., quality, good, fair, poor, incomplete) and limitations.

Cardiac Dimensions – Measurement
• Left ventricular internal systolic and diastolic dimensions.
• Left ventricular (basal) septal and posterior wall thickness.
• Left atrial size (anteroposterior dimension).
• Aortic root and ascending aorta dimensions

Evaluation of the structure and function of the anatomic components of the examination, to be included in the standard report, include the following:
• Assessment of left ventricular dimensions, wall thickness, global left ventricular systolic function and ejection fraction (and method used), and presence or absence of regional wall motion abnormalities.
• Evaluation of left ventricular diastolic function (if relevant to the clinical indication).
• Assessment of right ventricular size and systolic function, presence of right ventricular hypertrophy.
• Assessment of left atrium size.
• Assessment of right atrium size.
• Aortic valve cusp morphology, presence and severity of stenosis or regurgitation.
• Evaluation of gradients (peak and mean) and aortic valve area, if stenotic.
• Mitral valve leaflet morphology, presence and severity of stenosis or regurgitation.
• Evaluation of gradients (peak and mean) and mitral valve area, if stenotic.
• Tricuspid valve leaflet morphology, presence and severity of stenosis or regurgitation.

• Evaluation of gradients (peak and mean) for tricuspid valve, if stenotic.
• Estimation of right ventricular systolic pressure, if sufficient tricuspid regurgitation is present.
• Pulmonic valve morphology, presence and severity of stenosis or regurgitation.
• Evaluation of gradients (peak and mean) for pulmonic valve, if stenotic.
• Dimensions of Aorta (including aortic root and ascending aorta).
• Evaluation of Interatrial Septum (Intact – presence or absence of ASD/shunt).
• Presence and size of pericardial effusion, assessment of hemodynamic effects of pericardial effusion (if present).